Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial

: Nurmi Martti

: 2011

: Scandinavian Journal of Urology and Nephrology

: 5

: 45

: 5

: 346

: 353

: 8

: 0036-5599

DOI: https://doi.org/10.3109/00365599.2011.585820